United States · FDA National Drug Code directory
Rexulti
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59148-040_3a208135-0d99-4d6a-b73e-61d63cf48f4f
- Product NDC
- 59148-040
- Form
- TABLET
- Composition / generic term
- brexpiprazole
- Labeler
- Otsuka America Pharmaceutical, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20150710
- Source listing expiry
- 20271231
Source-listed ingredients
- BREXPIPRAZOLE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (59148-040-07) / 7 TABLET in 1 BLISTER PACK · 59148-040-07
- 1 BOTTLE in 1 CARTON (59148-040-13) / 30 TABLET in 1 BOTTLE · 59148-040-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →